1. Watts RA, Scott DG. Epidemiology of the vasculitides. Semin Respir Crit Care Med. 2004. 25:455–464.
Article
2. Ozen S, Pistorio A, Iusan SM, Bakkaloglu A, Herlin T, Brik R, et al. Paediatric Rheumatology International Trials Organisation (PRINTO). EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria. Ann Rheum Dis. 2010. 69:798–806.
Article
3. Dwyer JM, Kenicer K, Thompson BT, Chen D, LaBraico J, Schiefferdecker R, et al. Vasculitis and retinoids. Lancet. 1989. 2:494–496.
Article
4. Reynolds P, Fawcett H, Waldram R, Prouse P. Delayed onset of vasculitis following isotretinoin. Lancet. 1989. 2:1216.
Article
5. Aractingi S, Lassoued K, Dubertret L. Post-isotretinoin vasculitis. Lancet. 1990. 335:362.
Article
6. Epstein EH Jr, McNutt NS, Beallo R, Thyberg W, Brody R, Hirsch A, et al. Severe vasculitis during isotretinoin therapy. Arch Dermatol. 1987. 123:1123–1125.
Article
7. Chochrad D, Langhendries JP, Stolear JC, Godin J. Isotretinoin-induced vasculitis imitating polyarteritis nodosa, with perinuclear antineutrophil cytoplasmic antibody in titers correlated with clinical symptoms. Rev Rhum Engl Ed. 1997. 64:129–131.